[Serum zinc concentration and antibody response to hepatitis B vaccine in hemodialysis patients].
The serum zinc concentration seems unlikely to be an important factor influencing immune response to hepatitis B vaccination in hemodialysis patients, on the basis of the following results: the absence of statistically significant differences in serum zinc concentrations between patients with absence of post-vaccine seroconversion or non protective seroconversion and patients with excellent seroconversion (anti-HBs concentrations over 124.6 mUI/ml); the association of protective antibody responses in 50% of non responders after an additional dose of HBV vaccine, without preliminary corrections of zinc balance.
Migneco
G
G
Università degli Studi di Palermo, Cattedra di Fisiopatologia Medica.
Tripi
S
S
Navetta
A
A
La Ferla
A
A
Vaccaro
F
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005069:Evaluation Studies as Topic; D006510:Hepatitis B Antibodies / Q000032:analysis*; D017325:Hepatitis B Vaccines; D006801:Humans; D008875:Middle Aged; D006435:Renal Dialysis; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage / Q000276:immunology*; D015032:Zinc / Q000097:blood*
D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines; D015032:Zinc
Concentrazione sierica dello zinco e risposta anticorpale al vaccino anti-epatite B negli emodializzati.